Replies to post #12311 on Praxsyn Corp (PXYN)

[tutankhamen]

I don't disagree with you but everyday stocks shoot up for fairytales and fakery and here we have one that is real with a good story to tell. This stock has done nothing but decline from mid-May and now is stuck at a level that indicates failure. Perhaps there are still 50M shares to work through of the old Airway investors who got them at a penny and are happy with their 5x gains...i don't know. The math tells you where they are going and unless derailed by something unforeseen, should be nicely profitable as early as this quarter. The point is, PraXsyn IR is not putting their best foot forward or doing their fiduciary duties for investors and until we see them do that we should assume that much of the mispricing is related to radio silence.

[resolve]

You've mentioned "expansion expenses" multiple times in reference to moving into other states. What exactly are you referring to? Trestles Pain Management (TPS), headed by John Garbino, is leading the expansion with his company across the country. That's why we are giving them a 13% cut out of revenue and I have to assume it is for their expansion effort into other states. So, the expense is only incurred when revenue is generated. Again, they are taking 13% plus Garbino is getting shares. Be more specific with the expenses that seem to be such a hurdle in your mind. It does not appear that costly at all to produce product, rather, the major costs have been getting this merger off the ground which hopefully are soon behind us.